跳至主要内容
临床试验/DRKS00008721
DRKS00008721已完成不适用

Quality of life and treatment satisfaction with conventional systemic therapy in patients with psoriasis vulgaris - an observational study.

niversitätsklinikum Heidelberg0 个研究点目标入组 60 人开始时间: 2015年10月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 99 Years(—)
性别
All

入选标准

  • Patients with plaque psoriasis who begin therapy with a conventional systemic drug (Apremilast, methotrexate or Fumaderm) at the Department of Dermatology at the University of Heidelberg.
  • Patients must be at least 18 years old and give their written consent for study participation.

排除标准

  • Patients who are younger than 18 years of age, or are not fluent of the German language.
  • Furthermore, patients with psychiatric diagnoses are excluded.

研究者

发起方
niversitätsklinikum Heidelberg

相似试验